Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$1.87 -0.07 (-3.61%)
As of: Oct 21, 2026 · 3:50 PM EDT

Xtl Biopharmaceuticals (XTLB) Total Debt (2010 - 2025)

Updated

Xtl Biopharmaceuticals (XTLB) recorded Total Debt of $138,000 in the quarter ended Dec 31, 2025, unchanged from $138,000 a year earlier.

Analysis

Xtl Biopharmaceuticals (XTLB) Total Debt (2010 - 2025) Analysis & Trends

Starting with the quarter ended Dec 31, 2010, Xtl Biopharmaceuticals' Total Debt history includes 5 quarters.

  • Across earlier years, Total Debt came in at $138,000 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Xtl Biopharmaceuticals 16.76 Mn 13.56 Mn - 138,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 138,000.00
Jun 30, 2025 86,000.00
Dec 31, 2024 138,000.00
Sep 30, 2024 168,000.00
Dec 31, 2017 2.67 Mn
Dec 31, 2011 4.07 Mn
Dec 31, 2010 3.80 Mn
API Access

Xtl Biopharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=XTLB&period=max&api_key=YOUR_API_KEY